A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and mice Article

Kassa, Jiri, Karasova, Jana Zdarova, Kuca, Kamil et al. (2010). A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and mice . DRUG AND CHEMICAL TOXICOLOGY, 33(3), 227-232. 10.3109/01480540903483409

cited authors

  • Kassa, Jiri; Karasova, Jana Zdarova; Kuca, Kamil; Musilek, Kamil

sustainable development goals

authors

publication date

  • July 1, 2010

published in

keywords

  • ANTIDOTAL TREATMENT
  • BISPYRIDINIUM COMPOUNDS BEARING
  • CURRENTLY AVAILABLE OXIMES
  • Chemistry
  • Chemistry, Multidisciplinary
  • HI-6
  • IN-VIVO METHODS
  • K347
  • K628
  • Life Sciences & Biomedicine
  • NERVE AGENTS
  • ORGANOPHOSPHORUS COMPOUNDS
  • PARAOXON-INHIBITED ACETYLCHOLINESTERASE
  • PRALIDOXIME
  • Pharmacology & Pharmacy
  • Physical Sciences
  • Science & Technology
  • TRIMEDOXIME
  • Tabun
  • Toxicology
  • XYLENE LINKER
  • acetylcholinesterase
  • mice
  • obidoxime
  • rats
  • reactivation

Digital Object Identifier (DOI)

publisher

  • TAYLOR & FRANCIS INC

start page

  • 227

end page

  • 232

volume

  • 33

issue

  • 3